Clinical Effectiveness and Cost-Effectiveness of the New Genotype-specific Guidelines for Chronic Hepatitis C Treatment.

Wasem, Jürgen; Siebert, U.; Sroczynski, G.; Aidelsburger, P.; Rossol, S.; Manns, M.p.; McHutchison, J.g.; Wong, J.b.; (GEHMO) German Hepatitis C Model Group,; (IHIT) Int Hep Interv Therapy Group,

In den Korb XML MODS BibTeX EndNote RIS ISI Word 2007 Bib

Wasem, Jürgen; Siebert, U.; Sroczynski, G.; Aidelsburger, P.; Rossol, S.; Manns, M.p.; McHutchison, J.g.; Wong, J.b.; (GEHMO) German Hepatitis C Model Group, ; (IHIT) Int Hep Interv Therapy Group, :

Clinical Effectiveness and Cost-Effectiveness of the New Genotype-specific Guidelines for Chronic Hepatitis C Treatment.

In: 9th Biennial meeting of the European Society of Medical Decision Making, June 6-8.2004, Rotterdam, The Netherlands

Düsseldorf, Köln: German Medical Science (2004), S. 64

Buchaufsatz / Kapitel / Fach: Wirtschaftswissenschaften, Rechtswissenschaften

http://www.egms.de/en/meetings/gmds2004/04gmds119.shtml

http://www.egms.de/xml/meetings/gmds2004/04gmds119.xml

Dieser Eintrag ist freigegeben.

Universität Duisburg-Essen

DuEPublico

Wasem, Jürgen: Clinical Effectiveness and Cost-Effectiveness of the New Genotype-specific Guidelines for Chronic Hepatitis C Treatment.

Clinical Effectiveness and Cost-Effectiveness of the New Genotype-specific Guidelines for Chronic Hepatitis C Treatment.